体表血管瘤和脉管畸形的综合治疗临床观察

【】　目的　观察综合治疗体表血管瘤及脉管畸形的临床疗效。　方法　2008年1月-2010年9月，收治体表血管瘤和脉管畸形患者共205例。手术治疗156例，其中单纯手术治疗103例，合并介入治疗9例，硬化剂治疗44例；非手术治疗49例，其中介入治疗1例，硬化剂治疗38例，介入合并硬化剂治疗10例。术后随访6个月～3年。　结果　15例手术治疗患者于术后6个月～2年复发，其中单纯手术治疗患者10例（复发率9.71%），合并介入治疗患者2例（复发率22.22%），合并硬化剂治疗患者3例（复发率6.82%），均再次手术治疗后痊愈。9例非手术治疗患者于治疗后3个月～2年复发，其中8例硬化剂治疗患者，1例介入合并硬化剂治疗患者，均经手术治疗后痊愈。余患者未见复发。　结论　以手术治疗为主的综合治疗，是体表血管瘤和脉管畸形治疗的良好方法。【Abstract】　Objective　Toobservetheclinicaltherapeuticefficacyofcomprehensivetreatmentonbodysurfacehemangiomaandvascularmalformations.　Methods　BetweenJanuary2008andSeptember2010,205pateintswithsurfacehemangiomaandvascularmalformationweretreated.Atotalof156patientsreceivedsurgicaltreatment,inwhom103receivedsurgeryalone,9underwentcombinedinterventionaltreatment,and44receivedcombinedsclerotherapy.Therewere49patientsunderwentnon-surgicaltreatment,includinginterventionin1,sclerotherapyin38involving10hadcombinedsclerotherapy.Thepatientswerefollowedupfor6monthsto3years.　Results　Atotalof15patientswhohadreceivedsurgicaltreatmentrecurred6monthsto2yearsafterthetreatment,including10whohadbeentreatedwithsurgeryalone(withtherecurrencerateof9.71%),2combinedwithinterventionaltreatment(withtherecurrencerateof22.22%),and3combinedwithsclerotherapy(withtherecurrencerateof6.82%).Theywereallcuredafterreoperation.Ninecasesofnon-surgicaltreatmentrecurred3monthsto2yearsafterthetreatment,including8whohadreceivedsclerotherapy,and1combinedwithinterventionaltreatmentandsclerotherapy.Patientswereallcuredaftersurgery.Theotherpatientshadnorecurrence.　Conclusion　Applyingmainlyonsurgicaltreatment,thecombinedtherapyisagoodwayforbodysurfacehemangiomaandvascularmalformations.